Point72 »

Bioxcel Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $18 31 0.61
2024-06-30 $20k 15k 1.28

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Bioxcel Therapeutics

Armistice Capital
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Wells Fargo & Company
Renaissance Technologies
State Street Corporation
Morgan Stanley
Goldman Sachs Group
Bank of America Corporation
Citadel Advisors
Jane Street
Susquehanna International
Bnp Paribas Arbitrage, Snc

View all funds holding Bioxcel Therapeutics